BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 30347044)

  • 1. Diagnosis, Prognosis, and Treatment of Alveolar Soft-Part Sarcoma: A Review.
    Paoluzzi L; Maki RG
    JAMA Oncol; 2019 Feb; 5(2):254-260. PubMed ID: 30347044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel therapeutic options for alveolar soft part sarcoma: antiangiogenic therapy, immunotherapy and beyond.
    Brahmi M; Vanacker H; Dufresne A
    Curr Opin Oncol; 2020 Jul; 32(4):295-300. PubMed ID: 32541316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma.
    Reis H; Hager T; Wohlschlaeger J; Bauer S; Katenkamp K; Katenkamp D; Baba HA
    Hum Pathol; 2013 Oct; 44(10):2266-74. PubMed ID: 23871289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial.
    Judson I; Morden JP; Kilburn L; Leahy M; Benson C; Bhadri V; Campbell-Hewson Q; Cubedo R; Dangoor A; Fox L; Hennig I; Jarman K; Joubert W; Kernaghan S; López Pousa A; McNeil C; Seddon B; Snowdon C; Tattersall M; Toms C; Martinez Trufero J; Bliss JM
    Lancet Oncol; 2019 Jul; 20(7):1023-1034. PubMed ID: 31160249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of Immunological and Molecular Profiles with Response to Crizotinib in Alveolar Soft Part Sarcoma: An Exploratory Study Related to the EORTC 90101 "CREATE" Trial.
    Lee CJ; Modave E; Boeckx B; Kasper B; Aamdal S; Leahy MG; Rutkowski P; Bauer S; Debiec-Rychter M; Sciot R; Lambrechts D; Wozniak A; Schöffski P
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alveolar Soft Part Sarcoma of the Female Genital Tract: A Morphologic, Immunohistochemical, and Molecular Cytogenetic Study of 10 Cases With Emphasis on its Distinction From Morphologic Mimics.
    Schoolmeester JK; Carlson J; Keeney GL; Fritchie KJ; Oliva E; Young RH; Nucci MR
    Am J Surg Pathol; 2017 May; 41(5):622-632. PubMed ID: 28009610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain Metastases and Place of Antiangiogenic Therapies in Alveolar Soft Part Sarcoma: A Retrospective Analysis of the French Sarcoma Group.
    Malouf GG; Beinse G; Adam J; Mir O; Chamseddine AN; Terrier P; Honore C; Spano JP; Italiano A; Kurtz JE; Coindre JM; Blay JY; Le Cesne A
    Oncologist; 2019 Jul; 24(7):980-988. PubMed ID: 30626710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Phase II Trial of Pazopanib in Patients with Metastatic Alveolar Soft Part Sarcoma.
    Kim M; Kim TM; Keam B; Kim YJ; Paeng JC; Moon KC; Kim DW; Heo DS
    Oncologist; 2019 Jan; 24(1):20-e29. PubMed ID: 30254189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the Histogenesis and Diagnostic Strategy Using Immunoassay and RT-PCR in Alveolar Soft Part Sarcoma.
    Ju X; Sun K; Liu R; Li S; Abulajiang G; Zou H; Lan J; Ren Y; Jiang J; Liang W; Pang L; Li F
    Pathol Oncol Res; 2018 Jul; 24(3):593-600. PubMed ID: 28766250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alveolar soft part sarcoma: progress toward improvement in survival? A population-based study.
    Fujiwara T; Nakata E; Kunisada T; Ozaki T; Kawai A
    BMC Cancer; 2022 Aug; 22(1):891. PubMed ID: 35971085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary alveolar soft part sarcoma of the rectum resected by endoscopic submucosal dissection: A case report.
    Nakayama A; Yokota A; Suzuki Y; Iizuka T; Fukawa T; Ushiku T; Takazawa Y; Fujii T
    Pathol Int; 2020 Aug; 70(8):581-586. PubMed ID: 32515162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. iCREATE: imaging features of primary and metastatic alveolar soft part sarcoma from the EORTC CREATE study.
    Mcaddy NC; Saffar H; Litière S; Jespers P; Schöffski P; Messiou C
    Cancer Imaging; 2020 Oct; 20(1):79. PubMed ID: 33121537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective treatment of advanced alveolar soft part sarcoma with sunitinib: A case report.
    Ye C; Wang J; Li W; Yuan M; Chai Y
    Medicine (Baltimore); 2018 Dec; 97(51):e13584. PubMed ID: 30572461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Landscape in Alveolar Soft Part Sarcoma: Implications for Molecular Targeted Therapy.
    Soheilifar MH; Taheri RA; Zolfaghari Emameh R; Moshtaghian A; Kooshki H; Motie MR
    Biomed Pharmacother; 2018 Jul; 103():889-896. PubMed ID: 29710505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in treatment of alveolar soft part sarcoma: an updated review.
    Fujiwara T; Kunisada T; Nakata E; Nishida K; Yanai H; Nakamura T; Tanaka K; Ozaki T
    Jpn J Clin Oncol; 2023 Nov; 53(11):1009-1018. PubMed ID: 37626447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alveolar soft part sarcoma: a bimarker diagnostic strategy using TFE3 immunoassay and ASPL-TFE3 fusion transcripts in paraffin-embedded tumor tissues.
    Pang LJ; Chang B; Zou H; Qi Y; Jiang JF; Li HA; Hu WH; Chen YZ; Liu CX; Zhang WJ; Li F
    Diagn Mol Pathol; 2008 Dec; 17(4):245-52. PubMed ID: 18382356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of ASPL/TFE3 fusion transcripts and the TFE3 antigen in formalin-fixed, paraffin-embedded tissue in a series of 18 cases of alveolar soft part sarcoma: useful diagnostic tools in cases with unusual histological features.
    Williams A; Bartle G; Sumathi VP; Meis JM; Mangham DC; Grimer RJ; Kindblom LG
    Virchows Arch; 2011 Mar; 458(3):291-300. PubMed ID: 21279521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma.
    Pradhan D; Roy S; Quiroga-Garza G; Cieply K; Mahaffey AL; Bastacky S; Dhir R; Parwani AV
    Diagn Pathol; 2015 Sep; 10():179. PubMed ID: 26415891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revisiting cytomorphology, including unusual features and clinical scenarios of 8 cases of alveolar soft part sarcoma with TFE3 immunohistochemical staining in 7 cases.
    Rekhi B; Rao V; Ramadwar M
    Cytopathology; 2021 Jan; 32(1):20-28. PubMed ID: 32853443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents.
    Argani P; Antonescu CR; Illei PB; Lui MY; Timmons CF; Newbury R; Reuter VE; Garvin AJ; Perez-Atayde AR; Fletcher JA; Beckwith JB; Bridge JA; Ladanyi M
    Am J Pathol; 2001 Jul; 159(1):179-92. PubMed ID: 11438465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.